ATE361080T1 - Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine - Google Patents

Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine

Info

Publication number
ATE361080T1
ATE361080T1 AT02738611T AT02738611T ATE361080T1 AT E361080 T1 ATE361080 T1 AT E361080T1 AT 02738611 T AT02738611 T AT 02738611T AT 02738611 T AT02738611 T AT 02738611T AT E361080 T1 ATE361080 T1 AT E361080T1
Authority
AT
Austria
Prior art keywords
zidovudine
water soluble
lamivudine
pharmaceutically acceptable
active ingredient
Prior art date
Application number
AT02738611T
Other languages
English (en)
Inventor
Himadri Sen
Surya Kumar Jayanthi
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Application granted granted Critical
Publication of ATE361080T1 publication Critical patent/ATE361080T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT02738611T 2002-04-23 2002-04-23 Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine ATE361080T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000110 WO2003090762A1 (en) 2002-04-23 2002-04-23 Long acting compositions comprising zidovudine and lamivudine

Publications (1)

Publication Number Publication Date
ATE361080T1 true ATE361080T1 (de) 2007-05-15

Family

ID=29266770

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02738611T ATE361080T1 (de) 2002-04-23 2002-04-23 Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine

Country Status (12)

Country Link
US (1) US20050175694A1 (de)
EP (1) EP1501521B1 (de)
AT (1) ATE361080T1 (de)
AU (1) AU2002311622A1 (de)
BR (1) BR0215707A (de)
CZ (1) CZ20041117A3 (de)
DE (1) DE60219965T2 (de)
ES (1) ES2286258T3 (de)
HU (1) HUP0500217A2 (de)
MX (1) MXPA04010436A (de)
SK (1) SK285383B6 (de)
WO (1) WO2003090762A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5231242B2 (ja) * 2005-12-14 2013-07-10 シプラ・リミテッド ヌクレオチド及びヌクレオシド系逆転写酵素阻害剤（テノホビル及びラミブジン）を剤形の異なる部分に含む医薬組合せ
US20090258843A1 (en) * 2008-04-15 2009-10-15 Mallinckrodt Inc. Compositions Containing Antiviral Compounds and Methods of Using the Same
CN102488671A (zh) * 2011-12-15 2012-06-13 合肥华方医药科技有限公司 一种拉米夫定控释片制剂及其制备方法
CN113660928B (zh) * 2019-04-05 2024-04-05 盖迪亚生物技术公司 阴道片剂制剂
CN115813970B (zh) * 2022-11-25 2024-05-07 深圳福山生物科技有限公司 一种稳定释放的营养靶向组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036228A (en) * 1975-09-11 1977-07-19 Alza Corporation Osmotic dispenser with gas generating means
EP0654038B1 (de) * 1992-08-04 1999-11-10 James M. Dunn Pharmazeutische formulierungen mit kontrollierter freigabe von 3'-azido-3'-deoxythymidin und verfahren zur verwendung
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
EA004443B1 (ru) * 1998-09-14 2004-04-29 Рэнбакси Лабораториз Лимитед Лекарственная форма для контролируемого высвобождения ципрофлоксацина для приема один раз в день

Also Published As

Publication number Publication date
ES2286258T3 (es) 2007-12-01
EP1501521B1 (de) 2007-05-02
SK285383B6 (sk) 2006-12-07
CZ20041117A3 (cs) 2005-04-13
AU2002311622A1 (en) 2003-11-10
US20050175694A1 (en) 2005-08-11
BR0215707A (pt) 2005-05-03
MXPA04010436A (es) 2005-05-27
WO2003090762A1 (en) 2003-11-06
EP1501521A1 (de) 2005-02-02
DE60219965D1 (de) 2007-06-14
DE60219965T2 (de) 2008-01-17
HUP0500217A2 (hu) 2005-06-28
SK50222004A3 (sk) 2005-05-05

Similar Documents

Publication Publication Date Title
DK0923934T3 (da) Modified release-matrixformulering af cefaclor og cephalexin
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
WO2004108162A3 (en) Controlled release pharmaceutical composition
IE970588A1 (en) Controlled release pharmaceutical compositions containing tiagabine
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
RS20070511A (en) Modified release pharmaceutical compositions and processes thereof
WO2007048219A3 (en) Sustained drug release composition
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
HUP0203870A2 (hu) Adenozinreceptor agonistát vagy antagonistát tartalmazó gyógyászati készítmény
RU2333745C2 (ru) Композиции с контролируемым высвобождением
IL174830A0 (en) Pellets containing venlafaxine hydrochloride, pharmaceutical compositions comprising them and processes for their preparation
RS50937B (sr) Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii
CA2352211A1 (en) Sustained release matrix systems for highly soluble drugs
CO5060477A1 (es) Forma de dosificacion de nefazodona
CZ225596A3 (en) Film-coated tablets of paracetamol and domperidon
ATE549015T1 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
ATE361080T1 (de) Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
WO2004078111A3 (en) Extended release minocycline compositions and processes for their preparation
EP1765340A1 (de) Zusammensetzung mit verzögerter freisetzung für die orale verabreichung von niacin
UA89349C2 (uk) Таблетка без покриття, яка містить оланзапін, та спосіб її одержання
SG145717A1 (en) Composition for releasing a weak base for an extended period of time
PT1461017E (pt) Composicao farmaceutica para a libertacao controlada de um antibiotico beta-lactamico
NO20073850L (no) Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat
MXPA06007511A (es) Revestimientos de granulos de farmaco que imparten resistencia a la embarradura durante la compresion mecanica.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties